[Drug therapy in cardiac arrest: an overview]

Area of Science:

• Emergency Medicine
• Cardiology
• Pharmacology

Background:

• Cardiac arrest management involves medications to restore spontaneous circulation.
• Current vasopressors and antiarrhythmics aid circulation but not neurological recovery.
• Multimodal strategies are essential for reducing post-cardiac arrest morbidity and mortality.

Purpose of the Study:

• To provide an overview of current medications used in cardiac arrest management.
• To highlight the limitations of existing therapies regarding neurological outcomes.
• To emphasize the need for advanced research in post-cardiac arrest care, especially neuroprotection.

Main Methods:

• Literature review of vasopressor and antiarrhythmic drug efficacy in cardiac arrest.
• Analysis of current guidelines for prehospital and in-hospital cardiac arrest management.
• Discussion of the limited knowledge and ongoing research in post-cardiac arrest neuroprotection.

Main Results:

• Vasopressors and antiarrhythmics can achieve return of spontaneous circulation.
• No current medication has demonstrated improvement in survival with favorable neurological outcome.
• Optimal management requires a multimodal approach encompassing prehospital and post-admission care.

Conclusions:

• While medications can restore circulation in cardiac arrest, they do not guarantee improved neurological survival.
• Comprehensive, multimodal care is critical throughout the entire cardiac arrest continuum.
• Further research into neuroprotective drug therapies is urgently needed to improve patient outcomes.